Lawrence Pemble
Geschäftsführer bei CannBioRex Pharmaceuticals Corp.
Aktive Positionen von Lawrence Pemble
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CannBioRex Pharmaceuticals Corp.
CannBioRex Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology CannBioRex Pharmaceuticals Corp. is a research company that specializes in the clinical development of synthetic pharmaceutical grade cannabinoid compounds for the treatment in rheumatoid arthritis and related arthritic diseases. It also plans to develop novel orally available and patentable medications to treat arthritis, multiple sclerosis, diabetes, psoriasis, obesity and fatty liver, and various painful conditions. The company was founded by Marc Feldmann and Raphael Mechoulam on March 8, 2018 and is headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | 01.04.2018 | - |
Geschäftsführer | 01.05.2018 | - | |
Katexco Pharmaceuticals Corp.
Katexco Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Katexco Pharmaceuticals Corp. operates as medical marijuana company that engages in the development of orally available therapies harnessing endocannabinoid and nicotine receptors to treat inflammatory diseases. The company was founded by Jonathan Rothbard, Lawrence Steinman and Marc Feldmann and is headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | - | - |
Geschäftsführer | - | - | |
African Cannabis Corp.
African Cannabis Corp. Medical/Nursing ServicesHealth Services African Cannabis Corp. engages in providing cannabis products. It offers dried cannabis flower and cannabis oil products for medical uses. The firm's cannabis are used for the treatment of anxiety/stress disorders, metabolic disorders/diabetes, neuro inflammation, neurological disorders/epilepsy, oxidative injury, nausea and schizophrenia. The company was founded by Kojo Annan and Carl Esprey in 2018 and is headquartered in Toronto, Canada. | Geschäftsführer | - | - |
Karriereverlauf von Lawrence Pemble
Ehemalige bekannte Positionen von Lawrence Pemble
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AUSCAN RESOURCES INC. | Direktor/Vorstandsmitglied | 04.12.2017 | 09.11.2021 |
Vorstandsvorsitzender | 10.10.2018 | 05.06.2019 | |
Geschäftsführer | 04.12.2017 | 05.06.2019 | |
Finanzdirektor/CFO | 04.12.2017 | 05.06.2019 | |
Unternehmenssekretär | 04.12.2017 | 05.06.2019 | |
GLOBAL GAMING TECHNOLOGIES CORP. | Direktor/Vorstandsmitglied | 18.04.2019 | 15.08.2019 |
HEMOGENYX PHARMACEUTICALS PLC | Direktor/Vorstandsmitglied | 01.10.2017 | 05.11.2018 |
Geschäftsführer | 01.10.2017 | 05.11.2018 | |
GRAY FOX PETROLEUM CORP | Direktor/Vorstandsmitglied | 31.05.2013 | 02.04.2015 |
Vorstandsvorsitzender | 31.05.2013 | 02.04.2015 | |
Finanzdirektor/CFO | 31.05.2013 | 29.05.2014 | |
Präsident | 31.05.2013 | 02.04.2015 | |
Unternehmenssekretär | 31.05.2013 | 02.04.2015 | |
Treasurer | 31.05.2013 | 02.04.2015 | |
180 LIFE SCIENCES CORP. | Geschäftsführer | - | - |
Statistik
International
Kanada | 6 |
Vereinigte Staaten | 3 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 6 |
Chief Operating Officer | 6 |
Chief Executive Officer | 2 |
Sektoral
Health Technology | 5 |
Process Industries | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
HEMOGENYX PHARMACEUTICALS PLC | Health Technology |
AUSCAN RESOURCES INC. | Process Industries |
GLOBAL GAMING TECHNOLOGIES CORP. | Finance |
180 LIFE SCIENCES CORP. | Health Technology |
Private Unternehmen | 4 |
---|---|
CannBioRex Pharmaceuticals Corp.
CannBioRex Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology CannBioRex Pharmaceuticals Corp. is a research company that specializes in the clinical development of synthetic pharmaceutical grade cannabinoid compounds for the treatment in rheumatoid arthritis and related arthritic diseases. It also plans to develop novel orally available and patentable medications to treat arthritis, multiple sclerosis, diabetes, psoriasis, obesity and fatty liver, and various painful conditions. The company was founded by Marc Feldmann and Raphael Mechoulam on March 8, 2018 and is headquartered in Toronto, Canada. | Health Technology |
Grey Fox Holdings Corp.
Grey Fox Holdings Corp. RestaurantsConsumer Services Grey Fox Holdings Corp. was engaged in the acquisition of revenue generating subsidiaries to increase company revenues and shareholder value. The company was founded by Viatcheslav Gelshteyn on September 22, 2011 and was headquartered in Longwood, FL. | Consumer Services |
Katexco Pharmaceuticals Corp.
Katexco Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Katexco Pharmaceuticals Corp. operates as medical marijuana company that engages in the development of orally available therapies harnessing endocannabinoid and nicotine receptors to treat inflammatory diseases. The company was founded by Jonathan Rothbard, Lawrence Steinman and Marc Feldmann and is headquartered in Toronto, Canada. | Health Technology |
African Cannabis Corp.
African Cannabis Corp. Medical/Nursing ServicesHealth Services African Cannabis Corp. engages in providing cannabis products. It offers dried cannabis flower and cannabis oil products for medical uses. The firm's cannabis are used for the treatment of anxiety/stress disorders, metabolic disorders/diabetes, neuro inflammation, neurological disorders/epilepsy, oxidative injury, nausea and schizophrenia. The company was founded by Kojo Annan and Carl Esprey in 2018 and is headquartered in Toronto, Canada. | Health Services |
- Börse
- Insiders
- Lawrence Pemble
- Erfahrung